GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
+4.94%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.35B
AUM Growth
+$25.5M
(+1.9%)
Cap. Flow
-$626K
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$97.2M |
| 2 |
Apple
AAPL
|
+$8.26M |
| 3 |
Costco
COST
|
+$6.54M |
| 4 |
Tesla
TSLA
|
+$5.89M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$5.19M |
Top Sells
| 1 |
Lemonade
LMND
|
+$5.33M |
| 2 |
Porch Group
PRCH
|
+$4.71M |
| 3 |
Remitly
RELY
|
+$4.48M |
| 4 |
Magnite
MGNI
|
+$3.97M |
| 5 |
Monro
MNRO
|
+$3.65M |
Sector Composition
| 1 | Technology | 16.48% |
| 2 | Healthcare | 13.01% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Industrials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Vestis
VSTS
$537M
| $191K | 0.01% |
+12,533
| New | +$191K |
|
1427
Aviat Networks
AVNW
$289M
| $190K | 0.01% |
10,465
-9,361
| -47% | -$170K |
|
1428
Outlook Therapeutics
OTLK
$44.4M
| $190K | 0.01% |
+100,319
| New | +$190K |
|
1429
Neuronetics
STIM
$228M
| $189K | 0.01% |
117,142
+38,500
| +49% | +$62.1K |
|
1430
Nuvectis Pharma
NVCT
$160M
| $188K | 0.01% |
34,751
-15,378
| -31% | -$83.2K |
|
1431
Protara Therapeutics
TARA
$120M
| $188K | 0.01% |
+35,547
| New | +$188K |
|
1432
ARS Pharmaceuticals
SPRY
$1.04B
| $185K | 0.01% |
17,574
-81,326
| -82% | -$856K |
|
1433
Wrap Technologies
WRAP
$86.9M
| $185K | 0.01% |
87,460
+57,804
| +195% | +$122K |
|
1434
Core Laboratories
CLB
$577M
| $182K | 0.01% |
10,542
-12,858
| -55% | -$222K |
|
1435
FTAI Infrastructure
FIP
$486M
| $182K | 0.01% |
25,070
-108,663
| -81% | -$789K |
|
1436
Gerdau
GGB
$6.19B
| $182K | 0.01% |
+63,283
| New | +$182K |
|
|
NOAH
1437
Noah Holdings
NOAH
$787M
| $181K | 0.01% |
+15,447
| New | +$181K |
|
1438
PACS Group
PACS
$1.2B
| $181K | 0.01% |
13,779
-16,963
| -55% | -$223K |
|
1439
Full Truck Alliance
YMM
$14B
| $178K | 0.01% |
16,446
-29,728
| -64% | -$322K |
|
1440
Enanta Pharmaceuticals
ENTA
$178M
| $177K | 0.01% |
+30,726
| New | +$177K |
|
1441
Keros Therapeutics
KROS
$636M
| $177K | 0.01% |
+11,158
| New | +$177K |
|
1442
Certara
CERT
$1.65B
| $175K | 0.01% |
+16,414
| New | +$175K |
|
1443
Athira Pharma
ATHA
$15M
| $174K | 0.01% |
296,556
-100,555
| -25% | -$59K |
|
1444
Compañía de Cervecerías Unidas
CCU
$2.18B
| $174K | 0.01% |
+15,350
| New | +$174K |
|
1445
Torrid Holdings
CURV
$179M
| $174K | 0.01% |
33,342
-74,892
| -69% | -$391K |
|
|
DSL
1446
DoubleLine Income Solutions Fund
DSL
$1.44B
| $174K | 0.01% |
+13,871
| New | +$174K |
|
|
ARDT
1447
Ardent Health, Inc.
ARDT
$1.86B
| $172K | 0.01% |
+10,065
| New | +$172K |
|
|
CFB
1448
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $172K | 0.01% |
+11,347
| New | +$172K |
|
1449
Sight Sciences
SGHT
$179M
| $171K | 0.01% |
46,967
+25,453
| +118% | +$92.7K |
|
1450
ThredUp
TDUP
$1.33B
| $171K | 0.01% |
123,296
-32,258
| -21% | -$44.7K |
|